Researchers observed a significant disparity in colon cancer mortality related to origin location, independent of confounding variables.
The United States has remained near the bottom of the Bloomberg Health-Care Efficiency Index since its creation in 2012.
The population-based EUTOS registry demonstrated high overall and progression-free survival rates among patients with chronic myeloid leukemia.
Insurance status influences overall patient survival for some cancer types, but its impact on glioblastoma multiforme (GBM) survival is well documented. This research study explored the possible impact of insurance on GBM survival.
A recent study examined the possible correlation between Medicaid coverage status and overall survival for patients with head and neck cancer.
A post-hoc analysis of the Phase 3 ASPIRE study indicates that treatment combining carfilzomib with lenalidomide and dexamethasone extended survival time for patients with multiple myeloma.
Greatest survival benefit observed for those taking the drug before their cancer diagnosis.
Paclitaxel administered with carboplatin on a weekly basis is not associated with improved progression-free survival.
Intensive care unit survivors have higher mortality, use of hospital resources in five years after discharge.
Use of minimally invasive hysterectomy is linked to favorable morbidity profile and does not compromise long-term survival for patients.
Mortality rate changes in the United States since 1991 translate to an additional 1.7 million cancer survivors.
The longest survival time was observed for primary debulking surgery coupled with chemotherapy in an optimal timeframe.
Despite advances in treatment, finding smaller tumors has been linked to better survival results.
Nonsmokers more likely than smokers to be women and to have adenocarcinoma
Patients with metastatic nonsquamous non-small-cell lung cancer treated with nivolumab demonstrated greater survival.
A new study reveals that insurance status, marital status, and county-level income may affect survival for younger patients with AML, indicating that efforts are needed to address social factors that impact critical aspects of health.
Use of irreversible electroporation (IRE) doubles survival time for patients with locally advanced pancreatic cancer.
Predictors for long-term survival include younger age, early stage, low grade, non-serous histology
Despite survival benefits, only 41 percent of suitable candidates actually receive the therapy.
A recently compiled database that compares gene expression patterns to survival data could help predict survival outcomes for a variety of cancer types.
Effect of radiotherapy on survival of women with locally excised ductal carcinoma in situ of the breast: a Surveillance, Epidemiology, and End Results population-based analysisAugust 06, 2015
[OncoTargets and Therapy] This research examines the effect of radiotherapy on overall survival in women with locally excised ductal carcinoma in situ (DCIS).
Patients that cease smoking shortly before or after a lung cancer diagnosis experience significant survival benefits.
Despite treatment advances for adolescents and young adults with cancer, they still experience a higher rate of hospitalizations than the general public.
Receptors that mediate activity of the female sex hormones (estrogen and progesterone) interact with DNA to control the growth of a large majority of breast cancers, research indicates.
Almost two-thirds of patients with T4a larynx ("voice box") cancer are not receiving a total laryngectomy, despite published guidelines.
Eighty percent of lung cancer deaths linked to smoking, researchers say, and the mortality rate of several other cancers is also strongly impacted by smoking status.
Fewer childhood cancer survivors die of 'late effects' from radiation and chemotherapy, according to recent research.
Aspirin exposure after a colorectal cancer diagnosis was independently associated with improved colorectal cancer-specific survival.
Survival more likely with adherence to posttreatment surveillance, coupled with tobacco cessation.
Women diagnosed with ovarian cancer today are 50 percent less likely to die than they were in the 1970s.
- Ruxolitinib May Improve Symptom Control in Patients With CLL
- Obesity Increases Risk for Transformation of MGUS to Multiple Myeloma
- Racial Disparities Persist in Myeloma Treatment Use
- Adding Bortezomib to Rd Improves PFS, OS in Newly Diagnosed Myeloma
- Lutetium-177 Dotatate Improves PFS in Advanced Midgut Carcinoid Tumors
- Optimal Timing of Influenza Vaccination in Patients Receiving Chemotherapy
- Racial Disparities Persist in Myeloma Treatment Use
- Hypnosis and Its Use in Cancer Treatment
- Longer Dosing Interval of Zoledronic Acid May Be Acceptable for Bone Metastases
- Patients With Breast Cancer Report More Cognitive Difficulties After Chemotherapy
- Role of Oncology Nurse Navigators Has Evolved and Expanded in 5 Years
- Frailty Classifications Associated With Prognosis Among Older Patients
- Beach Umbrella Not Enough for Protection from UV Rays
- Comprehensive Report Looks at Benefits and Harms of Medical Cannabis
- ASCO: Moderate Activity Linked to Longer Survival in Advanced CRC
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|